BioCardia, Inc. (BCDA) vs Tvardi Therapeutics, Inc. (TVRD)

BioCardia, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. BioCardia, Inc. and Tvardi Therapeutics, Inc. are of similar size ($14.3M and $14.2M). BioCardia, Inc. grew revenue faster over the last twelve months: 0.71% against −34.4%. Across the 12 metrics below, BioCardia, Inc. leads on 6 and Tvardi Therapeutics, Inc. on 6.

Valuation

Metric BCDA TVRD Biotechnology median
P/E n/m n/m 8.50
P/S 25.99 0.85 9.71
P/B 4.12 1.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 30.15 4.79 9.21
Earnings yield (69.57%) (276.24%) (33.15%)
Free cash flow yield (68.06%) (297.28%) (25.50%)

Profitability

Metric BCDA TVRD Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,803.19%) (126.19%) (56.36%)
Return on assets (214.47%) (85.08%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCDA TVRD Biotechnology median
Revenue growth (TTM) 0.71% (34.36%) 6.02%
EPS growth (last fiscal year) 57.59% 79.51% 30.26%
Revenue growth, 5-year CAGR 26.89% (18.53%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.09 1.87 4.72
Net debt to EBITDA 0.30 1.15 0.96

Dividend

Metric BCDA TVRD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCDA TVRD Biotechnology median
Market cap 14.21m 14.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack